Skip to main content
VulnerabilityPublished

CVE-2024-44837: A Cross-site Scripting (XSS)

Source CVE Database V5

0

Not known to be exploited · CVSS 5.4 Medium.

Data as of 26 Oct 2026, 09:08 UTC

CVSS 3.1 base score
5.4Medium
How severe the flaw is on the 0–10 CVSS scale.
EPSS
0.3% chance of exploitation in 30 days – higher than 23% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N

Exploitation evidence

  1. Disclosed: evidence found.

    CVE published 6 Sep 2024

  2. Detectable: no evidence on record.

    No public nuclei template indexed

  3. Weaponised: no evidence on record.

    No public exploit code indexed in Metasploit or Exploit-DB

  4. Exploited in the wild: no evidence on record.

    Not in CISA KEV and no source reports exploitation

  5. Observed by OffSeq Mirage: no evidence on record.

    No attack traffic recorded by OffSeq Mirage sensors

A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 26 Oct 2026.

What to do

AI-suggested

To mitigate CVE-2024-44837, organizations should implement strict input validation and output encoding on the user parameter within the \bean\Manager.java component and any related input fields. Employing a robust web application firewall (WAF) configured to detect and block XSS payloads can provide an additional layer of defense. Developers should review and refactor the affected code to use secure coding practices, such as context-aware encoding libraries and frameworks that automatically sanitize user input. Since no official patches are currently available, organizations should monitor vendor communications for updates and apply patches promptly once released. Additionally, educating users about the risks of clicking on suspicious links and employing Content Security Policy (CSP) headers can reduce the impact of potential XSS attacks. Regular security assessments and penetration testing focused on XSS vulnerabilities will help identify and remediate similar issues proactively.

Description

A cross-site scripting (XSS) vulnerability in the component \bean\Manager.java of Drug v1.0 allows attackers to execute arbitrary web scripts or HTML via a crafted payload injected into the user parameter.

References

Community reviews

Loading reviews…